Txinno Bioscience is Drug Discovery in South Korea that focus on RAS mutated business. Founded in 2020. They cover business area such as developer, new drug, immunity, small-molecule compound, immunotherapy, RAS, anti-cancer drug, target cancer therapy, patient, well treatment.
2020
( 4 years old in 2024 )
RAS Mutated
-
Gwanggyo
South Korea
Private
developernew drugimmunitysmall-molecule compoundimmunotherapyRASanti-cancer drugtarget cancer therapypatientwell treatment
* We use standard office opening hours in near Txinno Bioscience's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Txinno Bioscience is Drug Discovery business from South Korea that founded in 2020 (4 years old in 2024), Txinno Bioscience business is focusing on RAS Mutated.
Txinno Bioscience headquarter office and corporate office address is located in Gwanggyo South Korea.
Txinno Bioscience was founded in South Korea.
In 2024, Txinno Bioscience is currently focus on RAS mutated sector.
Above is snippet of Google Trends for "RAS mutated" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Txinno Bioscience, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
